PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates
Indian online pharmacy startup PharmEasy, once valued at a lofty $5.6 billion, is still about 92% below its peak valuation, according to new estimates by its investor Janus Henderson. The …
PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates Read More